You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

ID: GL-END 3-21 jan 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
A. Finelli, T. Flood, G. Kulkarni, S. Hotte, M. O’Malley, The Genitourinary Cancer Advisory Committee

Guideline Objective

The objectives of this guideline are to provide clinical practice recommendations for the treatment of non-metastatic muscle-invasive bladder cancer (MIBC). Our recommendations are based on the 2017 American Urological Association (AUA) “Treatment of Non-Metastatic Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline”.

Patient Population

Patients with non-metastatic MIBC.

Intended Guideline Users

Primary care providers, urologists, radiation and medical oncologists, and other healthcare providers involved in the management of non-metastatic MIBC.

pdf download Full Report (PDF) (479.92 Ko)